Rekombinanter sCD40L (Toralizumab Biosimilar) Antikörper

Produktnummer ABIN7072676

Produktdetails anti-sCD40L (Toralizumab Biosimilar) Antikörper

Target: sCD40L (Toralizumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser sCD40L (Toralizumab Biosimilar) Antikörper ist unkonjugiert

Applikation: Blocking Reagent (BR), Immunofluorescence (IF)

Produktmerkmale:

Original Species of Ab: Mouse

Original Format of Ab: IgG1

Aufreinigung: Purified antibody.

Immunogen: The original monoclonal antibody was generated by immunization with a soluble fusion protein of human gp39 (gp39-CD8).

Klon: IDEC-131

Isotyp: IgG1 kappa

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Kommentare:

This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: PBS with 0.02 % Proclin 300.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Details zu sCD40L (Toralizumab Biosimilar)

Target: sCD40L (Toralizumab Biosimilar)

Abstract: sCD40L (Toralizumab Biosimilar) Produkte

Synonyme: CD154 antikoerper, CD40L antikoerper, HIGM1 antikoerper, IGM antikoerper, IMD3 antikoerper, T-BAM antikoerper, TNFSF5 antikoerper, TRAP antikoerper, gp39 antikoerper, hCD40L antikoerper, CD40 ligand antikoerper, CD40LG antikoerper

Substanzklasse: Biosimilar

Hintergrund: CD40L, gp39, TRAP, Tumor necrosis factor ligand superfamily member 5, TNFSF5, T-cell antigen Gp39, TNF-related activation protein, TNF-related activation protein

UniProt: P29965